KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.4M
- YoY, 2025
- −88.7%
- 5-year CAGR
- −30.7%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.4M | −88.7% |
| 2024 | $13M | −62.8% |
| 2023 | $34M | +1,115.8% |
| 2022 | $2.8M | +77.6% |
| 2021 | $1.6M | −82.4% |
| 2020 | $9.1M | +1,609.8% |
| 2019 | $532K | — |